NASDAQ: CKPTCheckpoint Therapeutics Inc Stock Forecast, Predictions & Price Target
Analyst price target for CKPT
Based on 5 analysts offering 12 month price targets for Checkpoint Therapeutics Inc.
Min Forecast
$15.00+468.18%
Avg Forecast
$29.80+1,028.79%
Max Forecast
$65.00+2,362.12%
Should I buy or sell CKPT stock?
Based on 5 analysts offering ratings for Checkpoint Therapeutics Inc.
Strong Buy
Strong Buy
4 analysts 80%
Buy
1 analysts 20%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Be the first to know when Wall Street analysts revise their CKPT stock forecasts and price targets.
CKPT stock forecasts by analyst
| Analyst / Firm | Rating | Action | Price Target | Upside/Downside | Date | Analyst Color |
|---|---|---|---|---|---|---|
| Strong Buy | Maintains | $16.00 | +506.06% | 2023-05-30 | ||
| Strong Buy | Maintains | $65.00 | +2,362.12% | 2023-05-17 | ||
| Strong Buy | Maintains | $19.00 | +619.70% | 2023-05-16 | ||
| Buy | Maintains | $34.00 | +1,187.88% | 2023-04-28 | ||
Anonymous Ladenburg Thalmann | Strong Buy | Maintains | $69.00 | +2,513.64% | 2023-04-03 | |
| Strong Buy | Maintains | $15.00 | +468.18% | 2022-12-19 | Find out why |
Forecast return on equity
Is CKPT forecast to generate an efficient return?
Company
N/A
Industry
0.07%
Market
70.69%
Forecast return on assets
Is CKPT forecast to generate an efficient return on assets?
Company
N/A
Industry
0.1%
CKPT revenue growth forecast
How is CKPT forecast to perform vs Biotechnology companies and vs the US market?
Company
849.1%
Industry
39.55%
Market
8.41%
CKPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CKPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast
CKPT vs Biotech Stocks
Checkpoint Therapeutics Stock Forecast FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.